Table 2.
Hormone levels
| Variable | Baseline | Oral TU | Placebo |
|---|---|---|---|
| Total testosterone (nmol/L) | 9.4 ± 2 | 10.2 ± 3.9 | 10.4 ± 2.4 |
| Free testosterone (nmol/L) | 0.23 ± 0.06 | 0.27 ± 0.1 | 0.25 ± 0.06 |
| (%) | 2.3 ± 0.5 | 2.7 ± 0.4⁎ | 2.4 ± 0.4 |
| Bioavailable testosterone (nmol/L) | 5.2 ± 1.6 | 6.3 ± 2.5 | 5.6 ± 1.4 |
| (%) | 52 ± 12 | 62 ± 10⁎ | 54 ± 10 |
| Dihydrotestosterone (nmol/L) | 1.18 ± 0.33 | 2.2 ± 1⁎ | 1.1 ± 0.3 |
| Sex hormone–binding globulin (nmol/L) | 29 ± 17 | 18.6 ± 7.7⁎ | 25.3 ± 10.8 |
| 17β-Estradiol (pmol/L) | 123 ± 75 | 141 ± 64 | 176 ± 102 |
| Follicular-stimulating hormone (IU/L) | 5.9 ± 2 | 4.2 ± 1.6⁎ | 5.8 ± 1.8 |
| Luteinizing hormone (IU/L) | 3.9 ± 2 | 2.1 ± 1.1⁎ | 3.8 ± 1.5 |
Values expressed as mean ± SD.
p <0.01 compared with placebo.